Here are three points:
1. EndoChoice has declined 60.1 percent since September 18, 2015 and is trending downward.
2. The company’s stock has underperformed the S&P500 by 66.73 percent.
3. The company has a market cap of $147.51 million.
More articles on GI/endoscopy:
Dr. Asad Rafiq joins Blessing Physician Services: 3 notes
Medtronic issues voluntary recall Capnostream monitor battery pack: 4 points
Dr. Steven Ayres designated AGA fellow — 5 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.